The Effect of Oral Polio Vaccine at Birth on Infant Mortality: A Randomized Trial

Najaaraq Lund, Andreas Andersen, Anna Sofie K Hansen, Frida S Jepsen, Amarildo Barbosa, Sofie Biering-Sørensen, Amabelia Rodrigues, Henrik Ravn, Peter Aaby, Christine Stabell Benn, Najaaraq Lund, Andreas Andersen, Anna Sofie K Hansen, Frida S Jepsen, Amarildo Barbosa, Sofie Biering-Sørensen, Amabelia Rodrigues, Henrik Ravn, Peter Aaby, Christine Stabell Benn

Abstract

Background: Routine vaccines may have nonspecific effects on mortality. An observational study found that OPV given at birth (OPV0) was associated with increased male infant mortality. We investigated the effect of OPV0 on infant mortality in a randomized trial in Guinea-Bissau.

Methods: A total of 7012 healthy normal-birth-weight neonates were randomized to BCG only (intervention group) or OPV0 with BCG (usual practice). All children were to receive OPV with pentavalent vaccine (diphtheria, tetanus, pertussis, Haemophilus influenzae type b, and hepatitis B) at 6, 10, and 14 weeks of age. Seven national OPV campaigns were also conducted during the trial period. Children were followed to age 12 months. We used Cox regression to calculate hazard ratios (HRs) for mortality.

Results: The trial contradicted the original hypothesis about OPV0 increasing male infant mortality. Within 12 months, 73 children in the BCG + OPV group and 87 children in the BCG-only group died, all from infectious diseases. Comparing BCG + OPV0 vs BCG only, the HR was 0.83 (95% confidence interval [CI], .61-1.13): 0.72 (95% CI, .47-1.10) in boys and 0.97 (95% CI, .61-1.54) in girls. For children enrolled within the first 2 days of life, the HR for BCG + OPV0 vs BCG only was 0.58 (95% CI, .38-.90). From enrollment until the time of OPV campaigns, the HR was 0.68 (95% CI, .45-1.00), the beneficial effect being separately significant for males (0.55 [95% CI, .32-.95]).

Conclusions: This is the only randomized trial of the effect of OPV0 on mortality. OPV0 may be associated with nonspecific protection against infectious disease mortality, particularly when given early in life. There are reasons to monitor mortality when OPV is being phased out.

Clinical trials registration: NCT00710983.

Keywords: heterologous immunity; infant mortality; neonates; nonspecific effects; oral polio vaccine.

© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America.

Figures

Figure 1.
Figure 1.
Flowchart of children randomized to BCG + oral polio vaccine at birth (OPV0) or BCG only, Guinea-Bissau, 2008–2011.
Figure 2.
Figure 2.
Cumulative mortality curves during infancy for children randomized to BCG + oral polio vaccine (OPV) at birth or BCG only, overall (A), for boys (B), and for girls (C). Follow-up was censored at the first day of the national OPV campaigns.

References

    1. Roth A, Jensen H, Garly ML et al. . Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau. Pediatr Infect Dis J 2004; 23:544.
    1. Roth A, Garly ML, Jensen H, Nielsen J, Aaby P. Bacillus Calmette-Guerin vaccination and infant mortality. Expert Rev Vaccines 2006; 5:277–93.
    1. Koenig MA, Khan MA, Wojtyniak B et al. . Impact of measles vaccination on childhood mortality in rural Bangladesh. Bull World Health Organ 1990; 68:441.
    1. Aaby P, Samb B, Simondon F et al. . Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 1995; 311:481–5.
    1. Aaby P, Bhuiya A, Nahar L et al. . The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh. Int J Epidemiol 2003; 32:106–15.
    1. Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 2000; 321:1435–8.
    1. Aaby P, Benn C, Nielsen J et al. . Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open 2012; 2.
    1. Benn CS, Netea MG, Selin LK, Aaby P. A small jab—a big effect: nonspecific immunomodulation by vaccines. Trends Immunol 2013; 34:431–9.
    1. Aaby P, Roth A, Ravn H et al. . Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis 2011; 204:245–52.
    1. Biering-Sorensen S, Aaby P, Napirna BM et al. . Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guerin vaccination at first health center contact. Pediatr Infect Dis J 2012; 31:306–8.
    1. Aaby P, Martins CL, Garly ML et al. . Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ 2010; 341:c6495.
    1. Aaby P, Jensen H, Gomes J, Fernandes M, Lisse IM. The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study. Int J Epidemiol 2004; 33:374.
    1. Aaby P, Jensen H, Walraven G. Age-specific changes in the female-male mortality ratio related to the pattern of vaccinations: an observational study from rural Gambia. Vaccine 2006; 24:4701–8.
    1. Aaby P, Biai S, Veirum JE et al. . DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau. Vaccine 2007; 25:1265–9.
    1. Aaby P, Benn CS, Nielsen J et al. . DTP vaccination and child survival in observational studies with incomplete vaccination data. Trop Med Int Health 2007; 12:15–24.
    1. Biai S, Rodrigues A, Nielsen J, Sodemann M, Aaby P. Vaccination status and sequence of vaccinations as risk factors for hospitalisation among outpatients in a high mortality country. Vaccine 2011; 29:3662–9.
    1. Veirum JE, Sodemann M, Biai S et al. . Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2005; 23:1197–204.
    1. Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 — conclusions and recommendations. Wkly Epidemiol Rec 2014; 89:221–36.
    1. Aaby P, Rodrigues A, Biai S et al. . Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2004; 22:3014–7.
    1. Aaby P, Hedegaard K, Sodemann M et al. . Childhood mortality after oral polio immunisation campaign in Guinea-Bissau. Vaccine 2005; 23:1746–51.
    1. Contreras G. Sabin's vaccine used for nonspecific prevention of infant diarrhea of viral etiology. Bull Pan Am Health Organ 1974; 8:123–32.
    1. Contreras G. Effect of the administration of oral poliovirus vaccine on infantile diarrhoea mortality. Vaccine 1989; 7:211–2.
    1. Global advisory group. Expanded programme on immunization. Wkly Epidemiol Rec 1985; 60:13–20.
    1. Benn CS, Fisker AB, Rodrigues A et al. . Sex-differential effect on infant mortality of oral polio vaccine administered with BCG at birth in Guinea-Bissau. A natural experiment. PLoS One 2008; 3:e4056.
    1. Sartono E, Lisse IM, Terveer EM et al. . Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment. PLoS One 2010; 5:e10328.
    1. Benn CS, Martins C, Rodrigues A, Lisse IM, Aaby P. Randomised study of the impact of different doses of vitamin A on childhood morbidity and mortality. BMJ 2005; 331:1428–32.
    1. Hansen AS, Lund N, Flanagan KL et al. . Randomized trial: the effect of oral polio vaccine at birth on polio antibody titers at 6 weeks and 6 months of age. Trials Vaccinol 2014; 3:33–9.
    1. Eriksen HB, Lund N, Biering-Sørensen S et al. . Does oral polio vaccine at birth affect the size of the thymus? Observations within a randomized trial. Vaccine 2014; 32:3293–9.
    1. Jensen KJ, Karkov HS, Lund N et al. . The immunological effects of oral polio vaccine provided with BCG vaccine at birth: a randomised trial. Vaccine 2014; 32:5949–56.
    1. Lund N, Andersen A, Monteiro I, Aaby P, Benn CS. No Effect of oral polio vaccine administered at birth on mortality and immune response to BCG. A natural experiment. Vaccine 2012; 20:6694–9.
    1. Benn CS, Diness BR, Roth A et al. . Effect of 50,000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial. BMJ 2008; 336:1416–20.
    1. Tourneur E, Chassin C. Neonatal immune adaptation of the gut and its role during infections. Clin Dev Immunol 2013; .
    1. Alam J, Rashid M, Kabir Y, Raqib R, Ahmad SM. On birth single dose live attenuated OPV and BCG vaccination induces gut cathelicidin LL37 responses at 6 week of age: a natural experiment. Vaccine 2015; 33:18–21.
    1. Lund N, Biering-Sørensen S, Andersen A et al. . Neonatal vitamin A supplementation associated with a cluster of deaths and poor early growth in a randomised trial among low-birth-weight boys of vitamin A versus oral polio vaccine at birth. BMC Pediatr 2014; 14:214.
    1. Kleinnijenhuis J, Quintin J, Preijers F et al. . Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A 2012; 109:17537–42.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅